RevoDx

Haemophilus Influenzae/Human Metapneumovirus/Mycoplasma pneumoniae qPCR Kit

The diagnosis of Haemophilus influenzae, Human Metapneumovirus, and Mycoplasma pneumoniae typically involves clinical evaluation and laboratory tests to confirm the presence of these bacterial pathogens, which are often associated with respiratory infections. Haemophilus influenzae, or H. influenzae, is a type of bacterium. It can lead to bacterial infections that vary in severity, from mild cases like bronchitis to serious conditions such as septic arthritis. Treatment typically involves antibiotics, and in severe cases, hospitalization may be necessary. Human metapneumovirus (HMPV) is a viral infection that typically causes cold-like symptoms. It may lead to coughing, wheezing, a runny nose, or a sore throat. While most cases are mild, young children, adults over 65, and individuals with weakened immune systems face a higher risk of severe illness. HMPV is widespread, with most people contracting it before the age of 5. Mycoplasma are a group of bacteria, some of which can cause disease in humans and animals. They are the smallest free-living organisms in terms of both size and genetic material. Unlike many other bacteria, they lack a cell wall. Mycoplasma pneumoniae is the primary human pathogen in this group and is responsible for respiratory infections, including upper respiratory tract infections, acute bronchitis, and community-acquired pneumonia. All three pathogens can be included in multiplex PCR assays for rapid and simultaneous detection, especially in respiratory infections, which can present with overlapping symptoms. This approach is especially valuable in clinical settings for timely treatment decisions.

Intended Use

RevoDx Haemophilus influenzae / Human Metapneumovirus / Mycoplasma pneumoniae qPCR Kit is a real-time PCR test intended for the qualitative detection and identification of nucleic acids of the Haemophilus influenzae, Human Metapneumovirus and Mycoplasma pneumoniae in human nasopharyngeal swab, oropharyngeal swab, nasopharyngeal aspirate/lavage, bronchoalveolar lavage (BAL), bronchial aspirate (BAS), sputum and cerebrospinal fluid (CSF) specimens from individuals with signs and/or symptoms of respiratory infection.